Trivascular Technologies (TRIV) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TRIV Annual Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Trivascular Technologies.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2015)
(Jun 30 2015) (Mar 31 2015) (Dec 31 2014) (Sep 30 2014)
Assets
Cash & cash equivalent34.89
Available-for-sale Securities, Current MA15.14
Cash & Short-term Investments49.00
Accounts receivable6.60
Inventories9.53
Prepaid Expense And Other Assets Current2.27
Total Current Assets68.43
Equipment/Property/Plant Net1.09
Goodwill net8.26
Intangible Assets1.18
Other Assets, Noncurrent0.83
Total Assets79.79
Liabilities
Accounts Payable, Current AC2.78
Total Current Liabilities9.61
Long-term debt65.33
Total Long-term Debt65.33
Other liabilities, Noncurrent3.34
Accrued Liabilities And Other Liabilities Current6.83
Total Liabilities78.27
Stockholders' Equity
Common Stock Value0.20
Additional Paid In Capital Common Stock341.40
Retained Earnings / Accumulated Deficit-339.97
Other Equity-0.11
Common Stockholder's Equity1.53
Total Stockholder's Equity1.53
Liabilities & Stockholder's Equity79.79
4 historic quarters locked

Sign in to unlock the full Trivascular Technologies balance sheet history.

About TRIV Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.